Total Funding
6
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2834042
Ancora Pharmaceuticals, Inc., a biopharmaceutical company, develops immune system modulation therapeutics using synthetic carbohydrates in
Acquired by 
CordenPharma
- Louis Schofield: Co-Founder
About the Company
Ancora Pharmaceuticals, Inc., a biopharmaceutical company, develops immune system modulation therapeutics using synthetic carbohydrates in the United States. Its products include vaccines against bacterial, parasitic, and viral infectious diseases, as well as therapeutics to treat cardiovascular and metabolic diseases. The company was incorporated
in 2001 and is based in Medford, Massachusetts. As of October 31, 2013, Ancora Pharmaceuticals, Inc. operates as a subsidiary of Corden Pharma Switzerland LLC.
